Cardio Intelligence, a startup in Japan, is addressing the issue of undetected atrial fibrillation, a leading risk factor for strokes. Their innovative AI technology, SmartRobin AI, provides clinicians with quick and simple insights from vast amounts of ECG data. The AI system has already been approved for detecting AFib in Japan, boasting high sensitivity and specificity rates. Unlike other AI solutions, Cardio Intelligence’s AI offers explainable results to aid in understanding diagnoses. The company plans to expand globally, particularly in Asia and North America, to improve cardiac care and patient outcomes worldwide through their ECG analysis AI solutions.
Source link
Leveraging ‘explainable AI’ to resolve Japan’s growing stroke threat
